How Healthcare M&A Firms De-Risk Concentration: Referral Sources, Payers, and Key Clinicians
How Healthcare M&A Firms De-Risk Concentration: Referral Sources, Payers, and Key Clinicians Key Takeaways Introduction In today’s healthcare mergers and acquisitions landscape, financial performance alone is no longer enough to secure a premium valuation. Buyers, private equity firms, and strategic investors are increasingly focused on operational stability and future resilience. One of the most critical […]
Read More
The Most Overlooked Metrics in Healthcare M&A Deals
The Most Overlooked Metrics in Healthcare M&A Deals Key Takeaways Introduction Healthcare M&A has become increasingly sophisticated, yet many deals are still evaluated using surface-level metrics that do not reflect the true health or long-term viability of an organisation. While revenue, EBITDA margins, and patient volume dominate conversations, these indicators only provide a limited snapshot […]
Read More